Tools and resources
The Confirmatory Mapping Survey Builder tool was designed to provide a more rigorous assessment of ongoing lymphatic filariasis transmission where initial mapping yielded inconclusive results. NTD-SC has also developed a web tool for analyzing complex survey data.
The TAS-STH Survey Sample Builder tool was designed to help capture the impact of lymphatic filariasis programs on soil-transmitted helminthiasis and provide guidance on whether ongoing mass drug administration is needed to control the transmission of intestinal worms.
LINKS is an Android app and web service that streamlines the data collection and reporting process. The system serves as a flexible platform which has supported more than 100 global health projects in over 50 countries. The app is available for free at the Google Play store.
On November 17-18, 2013 the Coalition for Operational Research on NTDs (COR-NTD) met immediately following the ASTMH conference in Washington DC. Presentations are shared below.
The NTD Mapping Tool is a new interactive mapping tool for control of neglected tropical diseases (NTDs).
This bench aid provides detailed instruction on the proper use of the new Filariasis Test Strip used for the detection of Wuchereria bancrofti antigen.
The Survey Sample Builder is a tool designed to help program managers with their Transmission Assessment Surveys. The SSB program can be used to automate the calculations for determining appropriate survey strategy. The design of the surveys is flexible in order to best fit the local situation and depends upon factors such as the primary school enrolment rate, the population size, the number of schools or enumeration areas, and the cost of different survey methods.
The Transmission Assessment Survey (TAS) for lymphatic filariasis is conducted to determine whether infection has been reduced to levels below which transmission is no longer sustainable, allowing for a decision to stop mass drug administration (MDA). The same strategy is also used for surveillance after stopping MDA to ensure that recrudescence is not occurring. These WHO guidelines are available in both French and English.